surf break copy_edited.jpg
surbreak-19.png
Search

Report: In big shift, medtech executives grow fonder of U.S. regulatory process

By: Joel Berg


Executives used to lean toward European regulators launching their products in that region. But after a decade of change, they now see the U.S. as a better option. While the FDA gets kudos, the other issue remains challenging: reimbursement.


CONTINUE READING

Recent Posts

See All
WM360_logo-18.png